Exclusion of Exon 2 Is a Common mRNA Splice Variant of Primate Telomerase Reverse Transcriptases

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Withers, Johanna B ^a,b   Ashvetiya, Tamara ^a   Beemon, Karen L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; EXON; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SEQUENCE; GENETIC CODE; GENETIC CONSERVATION; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOMAL FRAMESHIFTING; RNA STRUCTURE; TERT GENE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; COS CELLS; EXONS; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HUMANS; ISOENZYMES; MICE; NIH 3T3 CELLS; PHYLOGENY; PRIMATES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA SPLICING; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TELOMERASE;

MAMMALIA; PRIMATES;

EID: 84868139453     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048016     Document Type: Article

References (54)

1. Harley CB, Futcher AB, Greider CW, (1990) Telomeres shorten during aging of human fibroblasts. Nature 345(6274): 458-460.
2. Vazari H, Schachter F, Uchida I, Wei L, Zhu X, et al. (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52(4): 661-667.
3. Stewart SA, Weinberg RA, (2000) Telomerase and human tumorigenesis. Semin Cancer Biol 10(6): 399-406.
4. McElligott R, Wellinger RJ, (1997) The terminal DNA structure of mammalian chromosomes. EMBO J 16(12): 3705-3714.
5. Morin GB, (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59(3): 521-529.
6. Reddel RR, (2003) Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 194(2): 155-162.
7. Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW, (1997) Normal human choromosomes have long G-rich telomeric overhangs at one end. Genes Dev 11(21): 2801-2809.
8. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, et al. (1995) The RNA component of human telomerase. Science 269(5228): 1236-1241.
9. Greider CW, Blackburn EH, (1989) A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331-337.
10. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, et al. (1997) A mammalian telomerase-associated protein. Science 275(5302): 973-977.
11. Killan A, Bowtell DDL, Abud HE, Hume GR, Venter DJ, et al. (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patters in different cell types. Hum Mol Genet 6(12): 2011-2019.
12. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW, (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18(2): 173-179.
13. Yi X, Shay JW, Wright WE, (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29(23): 4818-4825.
14. Collins K, Mitchell JR, (2002) Telomerase in the human organism. Oncogene 21(4): 564-579.
15. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, et al. (1997) Reconstitution of human telomerase with the templace RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17(4): 498-502.
16. Xu D, Gruber A, Bjorkholm M, Peterson C, Pisa P, (1999) Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br J Cancer 80(8): 1156-1161.
17. Yi X, Tesmer VM, Savre-Train I, Shay JW, Wright WE, (1999) Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Biol 19(6): 3989-3997.
18. Saeboe-Larssen S, Fossberg E, Gaudernack G, (2006) Characterization of novel splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol Biol 7: 26.
19. Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Keinschmidt N, et al. (2010) Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 67(5): 677-700.
20. Robberson BL, Cote GJ, Berget SM, (1990) Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 10(1): 84-94.
21. International Human Genome Sequencing Consortium, (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.
22. Hoffman BE, Grabowski PJ, (1992) U1 snRNP targets an essential splicing factor U2AF65, to the 3′ splice site by a network of interactions spanning the exon. Genes Dev 6(12B): 2554-2568.
23. Berget SM, (1995) Exon recognition in vertebrate splicing. J Biol Chem 270: 2411-2414.
24. Bolisetty MT, Beemon KL (2012) Splicing of internal large exons is defined by novel cis-acting sequence elements. Nucleic Acids Research. doi:10:1093/nar/gks652.
25. Yi X, White DM, Aisner DL, Baur JA, Wright WE, et al. (2000) An alternative splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2(5): 433-440.
26. Freeman WM, Walker SJ, Vrana KE, (1999) Quantitative RT-PCR: Pitfalls and Potential. BioTechniques 26: 112-125.
27. Zentillin L, Giacca M, (2007) Competitive PCR for precise nucleic acid quantification. Nature Protocols 2: 2092-2104.
28. Marcand S, Brevet V, Mann C, Gilson E, (2000) Cell cycle restriction of telomere elongation. Curr Biol 10(8): 487-490.
29. Tomlinson RL, Ziegler TD, Supakorndej T, Terns RM, Terns MP, (2005) Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell 17(2): 955-965.
30. Armbruster BN, Banik SSR, Guo C, Smith AC, Counter CM, (2001) N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Mol Cell Biol 22: 7775-7786.
31. Manley JL, Tacke R, (1996) SR proteins and splicing control. Genes Dev 10(13): 1569-1579.
32. Long JC, Caceres JF, (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417(1): 15-27.
33. Gillis AJ, Schuller AP, Skordalakes E, (2008) Structure of the Tribolium castaneum telomerase catalytic subunit of TERT. Nature 455: 633-637.
34. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
35. Ulaner GA, Giudice LC, (1997) Developmental regulation of telomerase activity in human fetal tissues during gestation. Mol Hum Reprod 3: 769-773.
36. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR, (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58(18): 4168-4172.
37. Haendeler J, Hoffman J, Diehl JF, Vasa M, Spyridopoulos I, et al. (2004) Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 94(6): 768-775.
38. Maida Y, Yasukawa M, Furuuchi M, Lassmann T, Possemato R, et al. (2009) An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461(7261): 230-235.
39. Park J, Venteicher AS, Hong JY, Choi J, Jun S, et al. (2009) Telomerase modulates Wnt signaling by association with target gene chromatin. Nature 460(7251): 66-71.
40. Santos JH, Meyer JN, Van Houten B, (2006) Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet 15(11): 1757-1768.
41. Withers JB, Beemon KL (2011) The structure and function of the Rous sarcoma virus RNA stability element. Journal of Cellular Biochemistry doi: 10.1002/jcb.23272.
42. Sykorova E, Fajkus J, (2009) Structure-function relationships in telomerase genes. Biol. Cell 101: 375-392.
43. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DSK, et al. (1997) Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 11: 3109-3115.
44. Kelleher C, Teixeira MT, Förstemann K, Lingner J, (2002) Telomerase: biochemical considerations for enzyme and substrate. Trends Biochem Sci 27: 572-579.
45. Moriarty TJ, Marie-Egyptienne DT, Autexier C, (2004) Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer. Mol Cell Biol 24: 3720-3733.
46. O'Connor CM, Lai CK, Collins K, (2005) Two purified domains of telomerase reverse transcriptase reconstitute sequence-specific interactions with RNA. J Biol Chem 280: 17533-17539.
47. Jacobs SA, Podell ER, Cech TR, (2006) Crystal structure of the essential N-terminal domain of telomerase reverse transcriptase. Nat Struct Mol Biol 13: 218-225.
48. Romi E, Baran N, Gantman M, Shmoish M, Min B, et al. (2007) High-resolution physical and functional mapping of the template adjacent DNA binding site in catalytically active telomerase. Proc Natl Acad Sci USA 104: 8791-8796.
49. Wyatt HD, West SC, Beattie TL, (2010) InTERTpreting telomerase structure and function. Nucleic Acids Res 38: 5609-5622.
50. Robart AR, Collins K, (2011) Human telomerase domain interactions capture DNA for TEN domain-dependent processive elongation. Cell 42: 1-11.
51. Beattie TL, Zhou W, Robinson MO, Harrington L, (2000) Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding. Mol Biol Cell 11: 3329-3340.
52. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10(3): R25.
53. Livingstone CD, Barton GJ, (1993) Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation. Comput Appl Biosci 9(6): 745-756.
54. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ, (2009) Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25(9): 1189-1191.